单中心Ergonomix乳房假体临床应用经验
本回顾性研究报告一家私立手术中心使用Motiva Ergonomix SilkSurface乳房假体的早期经验,共纳入2014年4月至2018年10月由3位医生连续手术的356例患者,随访至少12个月,评估并发症发生率及医患双方对美学效果的满意度。结果显示356例(712个假体)中仅6例主要并发症,98%患者对美学效果极满意或非常满意,96%病例被医生判定为非常重要或重要的改善。
要点
- 356例(712个假体)中仅6例主要并发症,包括1例假体下垂(0.14%)和2例包膜挛缩(0.28%)。
- 所有时间点98%患者对美学效果极满意或非常满意,医生判定96%病例为非常重要或重要的改善。
- Motiva Ergonomix SilkSurface假体术后5年以上患者满意度高且并发症极少,与文献报道一致。
核心结论
- Motiva Ergonomix SilkSurface假体术后5年以上患者满意度高且并发症极少,数据与文献其他报道一致。
- 作者认为观察到的良好结果可能至少部分归因于这些假体的生物工程「细胞友好」表面。
研究设计与样本
- 回顾性研究,报告一家私立手术中心使用Motiva Ergonomix SilkSurface乳房假体的早期经验。
- 2014年4月至2018年10月由3位不同医生连续手术的356例患者接受Ergonomix SilkSurface乳房假体,随访至少12个月。
- 评估并发症包括破裂、包膜挛缩、位置异常、晚期血清肿、双包膜、再手术、对称乳房、下垂、挤出和感染,医患双方采用Likert量表评估美学满意度。
主要发现
- 356例患者(712个假体)中仅观察到6例主要并发症。
- 1例单侧假体下垂(「底部下移」)发生于12个月时(0.14%)。
- 2例包膜挛缩(0.28%),1例发生于14个月时,1例发生于2年时。
- 所有时间点98%患者对美学效果「极满意或非常满意」,医生在96%病例中将结果判定为「非常重要或重要的改善」。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This retrospective study reports on the early experience of a private surgical center with Motiva Ergonomix SilkSurface breast implants. OBJECTIVES: The aim of this study was to examine the incidence of complications and satisfaction levels in women who received primary and revision breast augmentation or augmentation-mastopexy with Ergonomix SilkSurface breast implants. METHODS: A total of 356 consecutive patients received Ergonomix SilkSurface breast implants between April 2014 and October 2018 by 3 different surgeons and were followed-up for a minimum of 12 months. Complications were assessed by measuring the rate of rupture, capsular contracture, malposition, late seroma, double capsule, reoperation, symmastia, ptosis, extrusion, and infection. Satisfaction with aesthetic results was assessed on a Likert scale by both surgeon and patient. RESULTS: Only 6 major complications were observed in these 356 patients (712 implants): 1 unilateral implant ptosis ("bottoming out") at 12 months (0.14%) and 2 capsular contractures (0.28%), 1 at 14 months and 1 at 2 years. At all time points, 98% of the patients were "extremely satisfied or very satisfied" with the aesthetic results, and the surgeons categorized the outcomes as "very important or important improvement" in 96% of the cases. CONCLUSIONS: Motiva Ergonomix SilkSurface devices provided high patient satisfaction up to more than 5 years postoperatively with very few complications. These data are consistent with other reports in the literature. The observed favorable outcomes might be attributed, at least in part, to the bioengineered "cell-friendly" surface of these implants.
引用
- Botti G, Botti C, Ciancio F, et al. A Single Center's Clinical Experience With Ergonomix Breast Implants. Aesthet Surg J. 2022. PMID: 34919632. doi:10.1093/asj/sjab422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。